Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma

Hepatology

Volumn 63, Issue 3, 2016, Pages 850-863

  Zhou, Chuan Chuan ^a   Yang, Fu ^a   Yuan, Sheng xIan ^a   Ma, Jin Zhao ^a   Liu, Feng ^a   Yuan, Ji Hang ^a   Bi, Feng Rui ^a   Lin, Kong Ying ^a   Yin, Jian Hua ^a   Cao, Guang Wen ^a   Zhou, Wei Ping ^a   Wang, Fang ^a   Sun, Shu Han ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; LONG UNTRANSLATED RNA; PROTEIN P53; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME 17P; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE LOSS; GENETIC SCREENING; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; UBIQUITINATION; ADULT; AGED; ANIMAL; CHINA; CHROMOSOME BREAKAGE; EPIDEMIOLOGY; FEMALE; GENETICS; INVERTED REPEAT; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MORTALITY; NUDE MOUSE; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CHINA; CHROMOSOME BREAKPOINTS; DNA COPY NUMBER VARIATIONS; FEMALE; GENES, P53; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INVERTED REPEAT SEQUENCES; LIVER NEOPLASMS; MALE; MICE, NUDE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS; RNA, LONG NONCODING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84959050769     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28393     Document Type: Article

References (38)

1. Hong SM, Vincent A, Kanda M, Leclerc J, Omura N, Borges M, et al. Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer. Clin Cancer Res 2013;18:4303-4312.
2. Li Y, Zhang L, Ball RL, Liang X, Li J, Lin Z, Liang H. Comparative analysis of somatic copy-number alterations across different human cancer types reveals two distinct classes of breakpoint hotspots. Hum Mol Genet 2012;21:4957-4965.
3. Fu L, Dong SS, Xie YW, Tai LS, Chen L, Kong KL, et al. Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma. Hepatology 2010;51:1624-1634.
4. Kwon SM, Kim DS, Won NH, Park SJ, Chwae YJ, Kang HC, et al. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype. Carcinogenesis 2013;34:1543-1550.
5. Tang YC, Amon A. Gene copy-number alterations: a cost-benefit analysis. Cell 2013;152:394-405.
6. Lau SH, Guan XY. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma. Acta Pharmacol Sin 2005;26:659-665.
7. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012;44:694-698.
8. Roessler S, Long EL, Budhu A, Chen Y, Zhao X, Ji J, et al. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology 2012;142:957-966.e12.
9. Lonigro RJ, Grasso CS, Robinson DR, Jing X, Wu YM, Cao X, et al. Detection of somatic copy number alterations in cancer using targeted exome capture sequencing. Neoplasia 2011;13:1019-1025.
10. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 2010;12:390-399.
11. Ma NF, Hu L, Fung JM, Xie D, Zheng BJ, Chen L, et al. Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. Hepatology 2008;47:503-510.
12. Gu DL, Chen YH, Shih JH, Lin CH, Jou YS, Chen CF. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma. World J Gastroenterol 2013;19:8873-8879.
13. Carrieri C, Cimatti L, Biagioli M, Beugnet A, Zucchelli S, Fedele S, et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 2012;491:454-457.
14. Maass PG, Rump A, Schulz H, Stricker S, Schulze L, Platzer K, et al. A misplaced lncRNA causes brachydactyly in humans. J Clin Invest 2012;122:3990-4002.
15. Ren S, Peng Z, Mao JH, Yu Y, Yin C, Gao X, et al. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res 2012;22:806-821.
16. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011;54:1679-1689.
17. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014;25:666-681.
18. Zhu J, Liu S, Ye F, Shen Y, Tie Y, Zhu J, et al. The long noncoding RNA expression profile of hepatocellular carcinoma identified by microarray analysis. PLoS One 2014;9:e101707.
19. Peng JC, Shen J, Ran ZH. Transcribed ultraconserved region in human cancers. RNA Biol 2013;10:1771-1777.
20. Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J, et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell 2014;26:344-357.
21. Wang K, Lim HY, Shi S, Lee J, Deng S, Xie T, et al. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma. Hepatology 2013;58:706-717.
22. Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 2011;44:667-678.
23. Quinn JJ, Ilik IA, Qu K, Georgiev P, Chu C, Akhtar A, Chang HY. Revealing long noncoding RNA architecture and functions using domain-specific chromatin isolation by RNA purification. Nat Biotechnol 2014;32:933-940.
24. Zhu LM, Shi DM, Dai Q, Cheng XJ, Yao WY, Sun PH, et al. Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma. Oncotarget 2014;5:5403-5415.
25. Lee MG, Han J, Jeong SI, Her NG, Lee JH, Ha TK, et al. XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313. Proc Natl Acad Sci U S A 2014;111:15532-15537.
26. Chao CC. Mechanisms of p53 degradation. Clin Chim Acta 2014;438C:139-147.
27. Muller PA, Vousden KH. p53 mutations in cancer. Nat Cell Biol 2013;15:2-8.
28. Tollini LA, Jin A, Park J, Zhang Y. Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage. Cancer Cell 2014;26:235-247.
29. Pant V, Lozano G. Limiting the power of p53 through the ubiquitin proteasome pathway. Genes Dev 2014;28:1739-1751.
30. Rawat S, Clippinger AJ, Bouchard MJ. Modulation of apoptotic signaling by the hepatitis B virus X protein. Viruses 2012;4:2945-2972.
31. Han ZG. Functional genomic studies: insights into the pathogenesis of liver cancer. Annu Rev Genomics Hum Genet 2012;13:171-205.
32. Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ, Huang J, Guan XY. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. Gut 2011;60:534-543.
33. Wade M, Li YC, Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 2013;13:83-96.
34. Hagn F, Lagleder S, Retzlaff M, Rohrberg J, Demmer O, Richter K, et al. Structural analysis of the interaction between Hsp90 and the tumor suppressor protein p53. Nat Struct Mol Biol 2011;18:1086-1093.
35. Galigniana MD, Harrell JM, O'Hagen HM, Ljungman M, Pratt WB. Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. J Biol Chem 2004;279:22483-22489.
36. Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell 2013;152:570-583.
37. Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 2013;493:231-235.
38. Liu X, Li D, Zhang W, Guo M, Zhan Q. Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J 2012;31:4415-4427.